Phospho-alpha Synuclein (Ser129) cellular kit

This HTRF kit enables the cell-based detection of phosphorylated alpha-synuclein at Ser129 as a marker of neurodegenerative diseases.

All inclusive kit
High sensitivity
Faster and more convenient than ELISA
No-wash

This HTRF kit enables the cell-based detection of phosphorylated alpha-synuclein at Ser129 as a marker of neurodegenerative diseases.

Taille

Référence sélectionnée: :

Quantité

En stock

Overview

The HTRF Phospho-alpha Synuclein (Ser129) cell-based assay kit is ideal for quantifying endogenous phospho-alpha Synuclein phosphorylated on Serine 129.

The alpha Synuclein protein is involved in the pathogenesis of synucleinopathies, a group of neurodegenerative diseases that includes Parkinson’s disease (PD), dementia with Lewy bodies (DLB), diffuse Lewy body disease (DLBD), and multiple system atrophy (MSA).

Benefits

SPECIFICITY
PRECISION

Phospho-Synuclein (Ser129) assay principle

The Phospho-alpha Synuclein (Ser129) assay measures Synuclein when phosphorylated at Ser129. Unlike Western Blot, the assay is entirely plate-based and does not require gels, electrophoresis or transfer.

The Phospho-Synuclein (Ser129) assay uses 2 labeled antibodies: one with a donor fluorophore, the other with an acceptor. The first antibody was selected for its specific binding to the phosphorylated motif on the protein, the second for its ability to recognize the protein independent of its phosphorylation state. Protein phosphorylation enables an immune-complex formation involving both the labeled antibodies, and which brings the donor fluorophore into close proximity to the acceptor, thereby generating a FRET signal. Its intensity is directly proportional to the concentration of phosphorylated protein present in the sample, and provides a means of assessing the protein’s phosphorylation state under a no-wash assay format.

Phospho-alpha Synuclein (Ser129) 2-plate assay protocol

The 2 plate protocol involves culturing cells in a 96-well plate before lysis, then transferring lysates into a 384-well low volume detection plate before adding Phospho-alpha Synuclein (Ser129) HTRF detection reagents.

This protocol enables the cells' viability and confluence to be monitored.

Phospho-TBK1 (Ser172) 2-plate assay protocol

Phospho-alpha Synuclein (Ser129) 1-plate assay protocol

Detection of Phospho-alpha Synuclein (Ser129) with HTRF reagents can be performed in a single plate used for culturing, stimulation, and lysis. No washing steps are required.

This HTS designed protocol enables miniaturization while maintaining robust HTRF quality.

Phospho-TBK1 (Ser172) 1-plate assay protocol

Phosphorylation of alpha Synuclein on Serine 129 in Human samples

HEK293 cells were transfected with a plasmid encoding alpha-Synuclein prior to seeding treatment with non phosphorylated fibrils. After cell lysis, different dilutions of lysate were analyzed by HTRF.

Phosphorylation of alpha synuclein was detected in human brain homogenates from patients with Lewy Body Diseases.

HEK293 cells transfected with alpha-Synuclein treated with fibril

Validation of phospho alpha synuclein (Ser129) kit in human brain samples

Phosphorylation of alpha Synuclein on Serine 129 in Mouse samples

The alpha Synuclein phosphorylation was detected on primary neurons obtained from WT mouse .

Inducible recombinant mouse N2A cells treated with non phosphorylated fibrils displayed high phosphorylation levels of alpha Synuclein.

Validation of phospho alpha synuclein (Ser129) kit in mouse neuron lysates

Validation of phospho alpha synuclein (Ser129) kit in mouse samples

Parkinson's disease pathway and a-synuclein role

Alpha-Synuclein is a prominent component of intracellular fibrillary aggregates in the brains of patients suffering from synucleinopathies. This protein represents a key molecular hallmark for Parkinson’s disease, dementia with Lewy bodies, or multiple system atrophy. The extensive phosphorylation of alpha synuclein on Ser129 is also associated with a pathological event.

Analysis of the effect of aggregated beta-Amyloid on cellular signaling pathways critical for memory in Alzheimer's disease

Changes in CREB and ERK phosphorylation levels after beta-amyloid treatment - Notes d'application

HTRF® phospho-protein platform facilitates the dissection of signaling pathways involved in insulin resistance and metabolic disorders

Multi-tissue cellular modeling and anlysis of insulin signaling - Posters

Simplify complex pathway dissection by combining the power of HTRF® cellular phospho-assays and the flexibility of the CyBi®-FeliX liquid handling system

PI3K/AKT/mTor translational control pathway - Posters

tab6

Protocoles

Product Insert a-Syn P-S129 Kit / 6FSYNPEG-6FSYNPEH
PDF (0.89 MB)

Vous serez peut-être intéressé par

MAP-Tau Kit

MAP-tau quantification in cell lysates

Alpha-Synuclein aggregation Kit

Alpha-Synuclein aggregation detection in cell and brain extracts

Phospho-LRRK2 (Ser935) cellular kit

Assay kit for the detection of Phospho-LRRK2 (Ser935)

Total LRRK2 cellular kit

All-in-one kit for robust detection of Total LRRK2

Tau Aggregation Kit

Tau aggregation detection in cell and brain extracts

Total alpha Synuclein cellular kit

Simple, all-in-one kit for robust detection of total alpha Synuclein

Phospho-TAU (Ser202/Thr205) cellular kit

Simple, all-in-one kit for robust detection of Phospho-TAU S202/T205

Phospho-Tau (Ser404) cellular kit

Simple, all-in-one kit for robust detection of Phospho-TAU S404